Company intelligence / Profile preview

Xedev

Zele, Vlaanderen, Belgium

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

Xedev does not have its own clinical results or pipeline as it operates as a contract research and development partner. It supports pharmaceutical and biotech companies in formulation and process development of solid materials from preformulation through to production of clinical batches up to Phase IIb. The company specializes in particle engineering using advanced drying, chilling/congealing, agglomeration, granulation, tableting, coating processes—especially spray drying—and offers analytical characterization services.

Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Partnerships

Sister company ProCepT provides R&D process equipment used by Xedev

Beyond the preview

Go deeper on Xedev.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xedev.

Explore the full profile